openPR Logo
Press release

Obesity Induced Diabetes Treatment Market to Witness a Staggering Growth between 2020 and 2030

11-26-2020 07:58 PM CET | Health & Medicine

Press release from: Persistence Market Research

Obesity develops due to nutritional excess and lack of exercise which causes adverse health outcomes such as cardiovascular disease, chronic kidney disease and type 2 diabetes. Obesity is main cause of type 2 diabetes. Obesity accounts for about 80-85% of risk for developing type 2 diabetes. In type 2 diabetes the body doesn’t use insulin properly which is commonly known as insulin resistance. Obesity induced diabetes is an emerging health problem worldwide. Increasing prevalence of obesity and diabetes worldwide and increasing economic burden significantly increase the healthcare expenditure globally.

According to NCBI, more than 2.1 billion people, nearly 30% of the population suffer from obesity. Obesity is no longer condition caused in older people, younger people have been diagnosed with obesity which causes type 2 diabetes in younger population. Fat in the abdomen causes fat cell which release pro-inflammatory chemicals, due to which the body becomes less sensitive to insulin and ability to respond to insulin. Increasing awareness and improving healthcare infrastructure in emerging market such as India, China which have strong emphasis on early detection and treatment of chronic conditions anticipate the growth of obesity induced diabetes treatment market.

Increasing prevalence of obesity and type 2 diabetes are the major factor which drive the market of obesity induced diabetes treatment globally. Significant increase in research and development in the treatment of diabetes and increasing advancement in diabetic medications by manufacturer fuel the growth of the obesity induced diabetes treatment market. However, lack of awareness among towards availability of medication hinder the growth of obesity induced diabetes treatment market. Lack of insurance facilities and poor healthcare infrastructure hinder the growth of the obesity induced diabetes treatment market.

For detailed insights on enhancing your product footprint, request for a Sample Report here https://www.persistencemarketresearch.com/samples/23095

The global obesity induced diabetes treatment market is segmented on basis of drug type, distribution channel and geographic region:

Segmentation by Drug Type
Biguanides
Sulfonylureas
Meglitinides
Thiazolidinediones
dipeptidyl peptidase IV inhibitors
α-glucosidase inhibitors
Others
To receive extensive list of important regions, ask for TOC here https://www.persistencemarketresearch.com/toc/23095

Segmentation by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-commerce
Segmentation by Geography
North America
Latin America
Europe
Asia-Pacific Excluding China
China
Middle East & Africa
On the basis of type of drug type, Biguanidesis extensively used over other drug type in obesity induced diabetes treatment market as Biguanidesis has advantages over drug class and offer effective results as it helps to promote weight loss. Also, rising incidence of obesity induced diabetes is anticipated to propel the market over the forecast period.

Based on end user, hospital pharmacies have the largest revenue share in the obesity induced diabetes treatment market owing to increasing awareness and early detection and diagnosis of diabetes. E-Commerce is the fastest growing segment owing to increasing demand of diabetes medication from end customers.

However, on the basis of geography, global obesity induced diabetes treatment market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. North America captured the largest shares in global obesity induced diabetes treatment market and is projected to continue over the forecast period owing to presence of high quality healthcare and increasing prevalence of obesity induced diabetes in this region. North America is followed by Europe which captures the second largest revenue shares in global obesity induced diabetes treatment market. However, Asia Pacific and China is expected to register a fast growth in obesity induced diabetes treatment during forecast period owing to rise in diabetes population and increase in awareness among the population.

Some of the key players present in global Obesity Induced Diabetes Treatment Market are Harman Finochem Ltd, EXEMED PHARMACEUTICALS, Boehringer Ingelheim International GmbH, AstraZeneca, Merck & Co., Inc, Johnson & Johnson Services, Inc, Eli Lilly and Company, and others.

For in-depth competitive analysis, Check Pre-Book here https://www.persistencemarketresearch.com/checkout/23095

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Obesity Induced Diabetes Treatment Market to Witness a Staggering Growth between 2020 and 2030 here

News-ID: 2196973 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Obesity

Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates. Anti Obesity Drugs Market Overview: The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.
03-18-2025 | Health & Medicine
Getnews
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success. Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss. Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930 This latest report researches the industry structure,
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close